Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP

International Journal of Cancer

Volumn 101, Issue 5, 2002, Pages 488-495

  Nakayama, Kentaro ^a,b   Kanzaki, Atsuko ^a   Ogawa, Kenji ^c   Miyazaki, Kohji ^b   Neamati, Nouri ^d   Takebayashi, Yuji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

ATP7B; Cisplatin; MDR; Ovarian carcinoma

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CISPLATIN; COPPER;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE TRIPHOSPHATASES; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; CATION TRANSPORT PROTEINS; CISPLATIN; CYTOKINES; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; MACROPHAGE INFLAMMATORY PROTEINS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 0037057531     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10608     Document Type: Article

References (51)

1. Long-term survival in ovarian cancer. Mature data from the Netherlands joint study group for ovarian cancer
2. Treatment of ovarian cancer: Current status
3. Biochemistry of multidrug resistance mediated by the multidrug transporter
4. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
5. Multidrug resistance-associated protein: Sequence correction
6. The drug resistance-related protein LRP is the human major vault protein
7. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine
8. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
9. Expression of a multidrug resistance gene in human cancers
10. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer
11. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
12. Analysis of expression cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
13. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
14. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
15. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
16. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors
17. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma
18. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
19. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
20. A multidrug resistance transporter from human MCF-7 breast cancer cells
21. The mouse Bcrp1/Mxr/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin
22. Methotrexate cross-resistance in a mitoxantrone-selected multidrug- resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux
23. Wilson disease and Menkes disease: New handles on heavy-metal transport
24. Functional analysis of copper homeostasis in cell culture models: A new perspective on internal copper transport
25. Wilson disease
26. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: Genomic organization, alternative splicing, and structure/function predictions
27. ATP7B (WND) protein
28. CPx-type ATPase: A class of P-type ATPase that pump heavy metals
29. The zntA gene of Escherichia coli encodes a Zn(II)-translocating P-type ATPase
30. Molecular basis for resistance to silver cations in Salmonella
31. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance
32. Changes in definitions of clinical staging for carcinoma of the cervix and ovary
33. Expression of a human multidrug resistance gene in ovarian carcinomas
34. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas
35. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer
36. MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors
37. Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma
38. Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer
39. Coexpression of the MDR1 gene and HSP27 in human ovarian cancer
40. Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas
41. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
42. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein
43. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
44. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines
45. A 190-kDa protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene
46. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen
47. Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles
48. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells
49. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines
50. Expression of multidrug resistance- related transporters in human breast carcinoma
51. Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas